Event Description

The Nanotechnology Characterization Laboratory (NCL) has made significant strides in advancing cancer nanotechnology over the past two decades. Established by the National Cancer Institute (NCI) in 2004 in collaboration with the US Food and Drug Administration (FDA) and the National Institute of Standards and Technology (NIST), the NCL has played a crucial role in bridging the gap between nanotechnology innovations and their clinical applications in oncology. The NCL serves as a resource and knowledgebase for all cancer researchers—academia, industry, and government—to facilitate the development and clinical translation of novel nanotechnologies intended as cancer therapeutics, vaccines, and diagnostics...

Hosted By

The Nanotechnology Characterization Laboratory (NCL)